Thermo-chemotherapy inhibits the proliferation and metastasis of gastric cancer cells via suppression of EIF5A2 expression
- PMID: 31496731
- PMCID: PMC6691964
- DOI: 10.2147/OTT.S215590
Thermo-chemotherapy inhibits the proliferation and metastasis of gastric cancer cells via suppression of EIF5A2 expression
Abstract
Purpose: Thermo-chemotherapy (TCT) is a new approach for the treatment of cancer that combines chemotherapy with thermotherapy. In the present study, we investigated the relationship between eukaryotic translation initiation factor 5A2 (EIF5A2) and TCT sensitivity in gastric cancer (GC) to further illuminate the molecular mechanism underlying the effect of TCT on GC.
Methods: A TCT cell model was constructed, and EIF5A2 was silenced or overexpressed by infection with a lentivirus expressing either EIF5A2 or EIF5A2 shRNA. Then, RT-qPCR, Western blotting, and immunohistochemistry assays were performed to evaluate the changes in the expression levels of EIF5A2, c-myc, vimentin, and E-cadherin. Cell proliferation and xenograft assays were conducted to evaluate the effect on cell proliferation. Finally, wound-healing and Transwell invasion assays were performed to evaluate the effects on migration and invasion.
Results: TCT reduced EIF5A2 expression at both the mRNA and protein levels. It also inhibited cell proliferation, migration, and invasion, downregulated the expression of c-myc and vimentin, and increased the expression of E-cadherin in both MKN28 and MKN45 cells. Silencing of EIF5A2 enhanced the above effects of TCT on MKN28 and MKN45 cells, while overexpression of EIF5A2 had the opposite effects. In addition, EIF5A2 overexpression weakened the inhibitory effect of TCT on tumor growth in vivo as well as the effects on c-myc, vimentin, and E-cadherin.
Conclusion: TCT inhibits GC cell proliferation and metastasis by suppressing EIF5A2 expression. Our results provide new insights into our understanding of the molecular mechanism underlying the effects of TCT in GC.
Keywords: EIF5A2; epithelial-mesenchymal transition; gastric cancer; proliferation; thermo-chemotherapy.
Conflict of interest statement
The authors have no conflicts of interest pertaining to this work.
Figures







Similar articles
-
[Effects of eukaryotic translation initiation factor 5A2 down-regulation by small interfering RNA on aggressiveness of MKN28 human].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2014 Oct;36(5):482-7. doi: 10.3881/j.issn.1000-503X.2014.05.005. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2014. PMID: 25360644 Chinese.
-
Overexpression of eukaryotic translation initiation factor 5A2 (EIF5A2) correlates with cell aggressiveness and poor survival in gastric cancer.PLoS One. 2015 Mar 20;10(3):e0119229. doi: 10.1371/journal.pone.0119229. eCollection 2015. PLoS One. 2015. PMID: 25793713 Free PMC article.
-
MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer.World J Gastroenterol. 2015 Aug 21;21(31):9337-47. doi: 10.3748/wjg.v21.i31.9337. World J Gastroenterol. 2015. PMID: 26309359 Free PMC article.
-
Eukaryotic initiation factor 5A2 and human digestive system neoplasms.World J Gastrointest Oncol. 2019 Jun 15;11(6):449-458. doi: 10.4251/wjgo.v11.i6.449. World J Gastrointest Oncol. 2019. PMID: 31236196 Free PMC article. Review.
-
Roles of eukaryotic initiation factor 5A2 in human cancer.Int J Biol Sci. 2013 Oct 12;9(10):1013-20. doi: 10.7150/ijbs.7191. eCollection 2013. Int J Biol Sci. 2013. PMID: 24250246 Free PMC article. Review.
Cited by
-
Establishment of a 5-gene risk model related to regulatory T cells for predicting gastric cancer prognosis.Cancer Cell Int. 2020 Sep 3;20:433. doi: 10.1186/s12935-020-01502-6. eCollection 2020. Cancer Cell Int. 2020. PMID: 32908454 Free PMC article.
-
The therapeutic efficacy of different configuration nano-polydopamine drug carrier systems with photothermal synergy against head and neck squamous cell carcinoma.Regen Biomater. 2024 Jun 20;11:rbae073. doi: 10.1093/rb/rbae073. eCollection 2024. Regen Biomater. 2024. PMID: 39027362 Free PMC article.
-
EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF- Signals.Oncol Res. 2020 Sep 1;28(4):345-355. doi: 10.3727/096504020X15834065061807. Epub 2020 Mar 5. Oncol Res. 2020. PMID: 32138807 Free PMC article.
-
Knockdown of lncRNA ZNRD1-AS1 suppresses gastric cancer cell proliferation and metastasis by targeting the miR-9-5p/HSP90AA1 axis.Aging (Albany NY). 2021 Jul 2;13(13):17285-17301. doi: 10.18632/aging.203209. Epub 2021 Jul 2. Aging (Albany NY). 2021. PMID: 34226297 Free PMC article.
-
Iron oxide nanoparticles coated with bioactive materials: a viable theragnostic strategy to improve osteosarcoma treatment.Discov Nano. 2025 Jan 30;20(1):18. doi: 10.1186/s11671-024-04163-w. Discov Nano. 2025. PMID: 39883285 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Miscellaneous